Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma

Clinical trial NCT05211232 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05211232
Sponsor: Sun Yat-sen University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2022-06-10
Primary completion: 2026-06-02
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.